|
|
Our StrategyAdcock Ingram's short to medium term strategy is based on a significant investment and recapitalisation programme which will drive our business objectives for the current local and future international markets. Our strategy envisages actively targeting synergistic acquisitions in selected therapeutic classes and expanding into the rest of Africa.
The Adcock Ingram Group's business strategy is based on leveraging the following key strengths:
- An industry leading footprint in branded prescription, OTC and hospital products, thus ensuring a loyal customer base of doctors, pharmacists, hospitals and retailers
- A leading corporate brand in the South African healthcare industry with a heritage of trusted quality
- The ability to attract, develop and retain key people in the industry
- Robust partnerships with key principals, a strong pipeline of innovation in core therapeutic categories and a planned entry into new niche therapeutic areas.
|